Session date: 
03/08/2017 - 7:30am to 8:30am

Learning Objectives:

1. Describe the classes of chemotherapeutic agents and their potential cardiovascular complications

2. Discuss guidelines for monitoring of cardiac function during therapy

3. Describe the possible cardiotoxic mechanisms of pembrolizumab

Presenter: 
Sithu Win, MBBS
Co-presenter: 
Quick Imaging: Michael Oien, MD
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota